Literature DB >> 25425310

Epiretinal membrane inflammatory cell density might reflect the activity of proliferative diabetic retinopathy.

Mojca Urbančič1, Špela Štunf1, Aleksandra Milutinović Živin2, Daniel Petrovič2, Mojca GlobočnikPetrovič1.   

Abstract

PURPOSE: Diabetic retinopathy (DR) has features of chronic low-grade inflammation. The purpose of our study was to investigate whether the presence of inflammatory cells in fibrovascular membranes (FVMs) from patients with proliferative diabetic retinopathy (PDR) is associated with the activity of PDR and visual acuity improvement after vitreoretinal surgery.
METHODS: Forty FVMs from 40 patients with PDR were obtained during vitrectomy, prepared by using the agar sandwich method, and examined using light microscope and immunohistochemistry methods to define the presence and density of inflammatory cells: CD45+ cells (leukocytes), CD4+ cells (T helper lymphocytes), CD8+ cells (T cytotoxic lymphocytes), CD19+ cells (B lymphocytes), and CD14+ cells (monocytes/macrophages). For each FVM, the inflammatory cell density defined as numerical areal density was calculated. The number of vessels was defined as the volume density of vessels.
RESULTS: Among 40 patients with PDR, 33 patients had active PDR and 7 quiescent PDR. Significant differences in cell densities for CD4+, CD8+, and CD19+ cells were observed between patients with active and quiescent PDR. B lymphocytes were present in membranes of active PDR only. No correlation was observed between numerical areal density of inflammatory cells and the volume density of vessels. No association was found between visual acuity improvement after surgery and cell densities.
CONCLUSIONS: Lymphocyte infiltration of FVMs might be associated with the activity of retinopathy but not with visual acuity improvement after surgery. © ARVO.

Entities:  

Keywords:  activity of retinopathy; fibrovascular membranes; inflammatory cells; lymphocyte infiltration; prognosis; proliferative diabetic retinopathy; visual acuity; vitreoretinal surgery

Mesh:

Year:  2014        PMID: 25425310     DOI: 10.1167/iovs.13-13634

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Comparison of histopathological findings between idiopathic and secondary epiretinal membranes.

Authors:  Mari Ueki; Seita Morishita; Ryohsuke Kohmoto; Masanori Fukumoto; Hiroyuki Suzuki; Takaki Sato; Takatoshi Kobayashi; Teruyo Kida; Hidehiro Oku; Tsunehiko Ikeda; Yuro Shibayama
Journal:  Int Ophthalmol       Date:  2016-02-08       Impact factor: 2.031

2.  Dysregulation of circulating follicular helper T cells in type 2 diabetic patients with diabetic retinopathy.

Authors:  Honghua Yu; Baoyi Liu; Guanrong Wu; Zijing Du; Qiaowei Wu; Xiaomin Zeng; Yu Xiao; Ying Fang; Ling Yuan; Suihong Ma; Tao Li
Journal:  Immunol Res       Date:  2021-02-24       Impact factor: 2.829

Review 3.  The Vitreomacular Interface in Diabetic Retinopathy.

Authors:  Daniel Agarwal; Rachel Gelman; Claudia Prospero Ponce; William Stevenson; John B Christoforidis
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

4.  Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.

Authors:  Mojca Urbančič; Daniel Petrovič; Aleksandra Milutinović Živin; Peter Korošec; Matjaž Fležar; Mojca Globočnik Petrovič
Journal:  Mol Vis       Date:  2020-06-26       Impact factor: 2.367

Review 5.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.

Authors:  Amjad A Khan; Mohammed A Alsahli; Arshad H Rahmani
Journal:  Med Sci (Basel)       Date:  2018-04-18

Review 6.  Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?

Authors:  Esraa Shosha; Abdelrahman Y Fouda; S Priya Narayanan; R William Caldwell; Ruth B Caldwell
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

7.  A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane.

Authors:  Ahmed Abdelshafy Tabl; Tarek Tawfik Soliman; Mohamed Anany Elsayed; Marwa Abdelshafy Tabl
Journal:  J Ophthalmol       Date:  2022-01-21       Impact factor: 1.909

8.  In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.

Authors:  Stefaniya Konstantinova Boneva; Julian Wolf; Rozina Ida Hajdú; Gabriele Prinz; Henrike Salié; Anja Schlecht; Saskia Killmer; Yannik Laich; Henrik Faatz; Albrecht Lommatzsch; Martin Busch; Felicitas Bucher; Andreas Stahl; Daniel Böhringer; Bertram Bengsch; Günther Schlunck; Hansjürgen Agostini; Clemens A K Lange
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

9.  Bcl-6-directed follicular helper T cells promote vascular inflammatory injury in diabetic retinopathy.

Authors:  Yan Liu; Ziqi Yang; Peilong Lai; Zijing Huang; Xiaowei Sun; Tian Zhou; Chang He; Xialin Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

10.  Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort.

Authors:  Emin Grbić; Nataša Gorkič; Aleš Pleskovič; Marjeta Zorc; Farid Ljuca; Mladen Gasparini; Božidar Mrđa; Ines Cilenšek; Sara Mankoč; Maciej Banach; Daniel Petrovič; Zlatko Fras
Journal:  Lipids Health Dis       Date:  2020-04-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.